source
- Galapagos spinout Coultreon raises $125M for new take on SIK inhibitionCoultreon Biopharma has patched together $125 million from some of the largest biotech investors in the US and Europe in a bid to join the burgeoning pipeline-in-a-pill approach to autoimmune disea…Endpoints · 3mo ago↗ source
- Biotech investors gamble on M&A. Some drugmakers are betting on themselves instead.Young biotechs usually get acquired instead of profitably selling their own medicines. A growing number are proving they can, which could make the sector more broadly appealing to investors, some say.BioPharma Dive · 3mo ago↗ source
- STAT+: Eli Lilly enlists AI startup for next-generation gene editorsEli Lilly's deal with Profluent aims to go beyond CRISPR by using AI-designed enzymes to insert entire genes. It could reshape genetic medicine.